Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Accenture
Federal Trade Commission
Medtronic
Boehringer Ingelheim
Fish and Richardson
Cerilliant
Farmers Insurance
Covington

Generated: February 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DROSPIRENONE AND ETHINYL ESTRADIOL

« Back to Dashboard

Clinical Trials for Drospirenone And Ethinyl Estradiol

Trial ID Title Status Sponsor Phase Summary
NCT00413062 Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722) Completed Merck Sharp & Dohme Corp. Phase 3 The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years.
NCT00511199 Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724) Completed Merck Sharp & Dohme Corp. Phase 3 The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years.
NCT00511433 Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723) Completed Merck Sharp & Dohme Corp. Phase 3 The primary purpose of this study is to evaluate the effects of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) on ovarian function.
NCT00567164 Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ Completed Bayer Phase 3 The purpose of this study is to determine whether the study drug is safe and effective.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Drospirenone And Ethinyl Estradiol

Condition Name

Condition Name for Drospirenone And Ethinyl Estradiol
Intervention Trials
Contraception 10
Polycystic Ovary Syndrome 4
Healthy 4
Acne Vulgaris 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Drospirenone And Ethinyl Estradiol
Intervention Trials
Polycystic Ovary Syndrome 4
Acne Vulgaris 3
Syndrome 3
Insulin Resistance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Drospirenone And Ethinyl Estradiol

Trials by Country

Trials by Country for Drospirenone And Ethinyl Estradiol
Location Trials
United States 82
China 19
Germany 14
United Kingdom 6
Austria 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Drospirenone And Ethinyl Estradiol
Location Trials
California 5
Massachusetts 5
Pennsylvania 5
Florida 4
Arizona 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Drospirenone And Ethinyl Estradiol

Clinical Trial Phase

Clinical Trial Phase for Drospirenone And Ethinyl Estradiol
Clinical Trial Phase Trials
Phase 4 7
Phase 3 15
Phase 2 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Drospirenone And Ethinyl Estradiol
Clinical Trial Phase Trials
Completed 20
Not yet recruiting 3
Recruiting 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Drospirenone And Ethinyl Estradiol

Sponsor Name

Sponsor Name for Drospirenone And Ethinyl Estradiol
Sponsor Trials
Bayer 12
Massachusetts General Hospital 3
Merck Sharp & Dohme Corp. 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Drospirenone And Ethinyl Estradiol
Sponsor Trials
Industry 22
Other 11
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Julphar
Covington
Accenture
Moodys
Boehringer Ingelheim
Queensland Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.